Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections.

Clin Infect Dis · 2011 · PMC3156139 · PMID 21844027

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

marginally significantP = .06so close (0.05 < p ≤ 0.1)

In contrast, only 17.74% of those who received no CAs after completing treatment experienced recurrence, and the difference was marginally significant (−7.1% difference [95% CI, −15.3% to 0.60%]; P = .06).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.